We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
35 hedge funds and large institutions have $47.3M invested in scPharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 7
3% more capital invested
Capital invested by funds: $45.8M → $47.3M (+$1.5M)
0.26% less ownership
Funds ownership: 43.65% → 43.39% (-0.26%)
15% less funds holding
Funds holding: 41 → 35 (-6)
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Holders
35
Holders Change
-6
Holders Change %
-14.63%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
14
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AIC
AWM Investment Company
New York
|
+$326K |
| 2 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$170K |
| 3 |
JP Morgan Chase
New York
|
+$107K |
| 4 |
State Street
Boston,
Massachusetts
|
+$84.9K |
| 5 |
Bank of New York Mellon
New York
|
+$26.7K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$267K |
| 2 |
Goldman Sachs
New York
|
-$150K |
| 3 |
CG
Colony Group
Boston,
Massachusetts
|
-$131K |
| 4 |
Millennium Management
New York
|
-$109K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$95K |
